https://www.selleckchem.com/pr....oducts/6-diazo-5-oxo
905, AUC = 0.922, respectively). Conclusion Serum PDGF may be a potential biomarker for diagnosis of patients with NSCLC and SCLC. However, the prognostic value of serum PDGF in patients with NSCLC harboring mutations and different therapies requires additional investigation. © 2020 Ma et al.Introduction Esophageal squamous cell carcinoma (ESCC) is the predominant type of esophageal carcinoma with a low survival rate and a poor prognosis. Therefore, it is of great significance to explore the effective tumor markers in
Like
Comment
Share
